S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
This Stock Could Rebound Quick (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
How to Find Penny Stocks to Invest and Trade
Is This Stock On Your Radar (Ad)
Can Cummins Power To A New High? 
ONSemi Is Marching Higher On Great Results
Is This Stock On Your Radar (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Here’s the Silver Lining with Snap Stock Earnings Collapse
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
This Stock Could Rebound Quick (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
How to Find Penny Stocks to Invest and Trade
Is This Stock On Your Radar (Ad)
Can Cummins Power To A New High? 
ONSemi Is Marching Higher On Great Results
Is This Stock On Your Radar (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Here’s the Silver Lining with Snap Stock Earnings Collapse
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
This Stock Could Rebound Quick (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
How to Find Penny Stocks to Invest and Trade
Is This Stock On Your Radar (Ad)
Can Cummins Power To A New High? 
ONSemi Is Marching Higher On Great Results
Is This Stock On Your Radar (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Here’s the Silver Lining with Snap Stock Earnings Collapse
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
This Stock Could Rebound Quick (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
How to Find Penny Stocks to Invest and Trade
Is This Stock On Your Radar (Ad)
Can Cummins Power To A New High? 
ONSemi Is Marching Higher On Great Results
Is This Stock On Your Radar (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Here’s the Silver Lining with Snap Stock Earnings Collapse
NASDAQ:FBIO

Fortress Biotech - FBIO Stock Forecast, Price & News

$0.83
-0.02 (-2.36%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.81
$0.90
50-Day Range
$0.48
$1.10
52-Week Range
$0.48
$2.10
Volume
341,090 shs
Average Volume
500,780 shs
Market Capitalization
$89.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00

Fortress Biotech MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
623.9% Upside
$6.00 Price Target
Short Interest
Healthy
0.51% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$68,000 Bought Last Quarter
Proj. Earnings Growth
Decreasing
From ($0.92) to ($1.05) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.35 out of 5 stars

Medical Sector

88th out of 1,027 stocks

Pharmaceutical Preparations Industry

34th out of 500 stocks

FBIO stock logo

About Fortress Biotech (NASDAQ:FBIO) Stock

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Receive FBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fortress Biotech and its competitors with MarketBeat's FREE daily newsletter.

FBIO Stock News Headlines

Is This Stock On Your Radar
This stock is positioned like its peers that cashed out.
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
See More Headlines
Receive FBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fortress Biotech and its competitors with MarketBeat's FREE daily newsletter.

FBIO Company Calendar

Last Earnings
11/14/2022
Today
2/07/2023
Next Earnings (Estimated)
3/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
NASDAQ:FBIO
CUSIP
21976U10
Employees
173
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.00
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+623.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-64,700,000.00
Net Margins
-117.49%
Pretax Margin
-289.25%

Debt

Sales & Book Value

Annual Sales
$68.79 million
Book Value
$2.27 per share

Miscellaneous

Free Float
79,401,000
Market Cap
$89.31 million
Optionable
Optionable
Beta
1.91

Key Executives

  • Lindsay Allan Rosenwald
    Chairman, President & Chief Executive Officer
  • David Jin
    CFO & Head-Corporate Development
  • George C. Avgerinos
    Senior Vice President-Biologics Operations
  • Michael Sean Weiss
    Director & Vice Chairman-Strategic Development
  • Brian Achenbach
    Vice President-Finance & Controller













FBIO Stock - Frequently Asked Questions

Should I buy or sell Fortress Biotech stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fortress Biotech in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" FBIO shares.
View FBIO analyst ratings
or view top-rated stocks.

What is Fortress Biotech's stock price forecast for 2023?

4 analysts have issued 1 year price targets for Fortress Biotech's shares. Their FBIO share price forecasts range from $6.00 to $6.00. On average, they expect the company's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 623.9% from the stock's current price.
View analysts price targets for FBIO
or view top-rated stocks among Wall Street analysts.

How have FBIO shares performed in 2023?

Fortress Biotech's stock was trading at $0.6550 on January 1st, 2023. Since then, FBIO stock has increased by 26.5% and is now trading at $0.8289.
View the best growth stocks for 2023 here
.

Are investors shorting Fortress Biotech?

Fortress Biotech saw a decline in short interest in January. As of January 15th, there was short interest totaling 391,700 shares, a decline of 51.3% from the December 31st total of 804,100 shares. Based on an average daily trading volume, of 395,800 shares, the short-interest ratio is presently 1.0 days. Approximately 0.5% of the shares of the stock are sold short.
View Fortress Biotech's Short Interest
.

When is Fortress Biotech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 27th 2023.
View our FBIO earnings forecast
.

How were Fortress Biotech's earnings last quarter?

Fortress Biotech, Inc. (NASDAQ:FBIO) posted its quarterly earnings results on Monday, November, 14th. The biopharmaceutical company reported ($0.25) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.02. The biopharmaceutical company earned $16.53 million during the quarter, compared to analysts' expectations of $19.02 million. Fortress Biotech had a negative net margin of 117.49% and a negative trailing twelve-month return on equity of 54.56%.

What other stocks do shareholders of Fortress Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fortress Biotech investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Novavax (NVAX), Advanced Micro Devices (AMD), OPKO Health (OPK), TG Therapeutics (TGTX), Vaxart (VXRT), NVIDIA (NVDA), Pfizer (PFE) and Dynavax Technologies (DVAX).

What is Fortress Biotech's stock symbol?

Fortress Biotech trades on the NASDAQ under the ticker symbol "FBIO."

Who are Fortress Biotech's major shareholders?

Fortress Biotech's stock is owned by a number of institutional and retail investors. Top institutional investors include Perkins Capital Management Inc. (0.76%), 1900 Wealth Management LLC (0.12%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Eric K Rowinsky, Lindsay A Md Rosenwald, Malcolm Hoenlein and Robyn Hunter.
View institutional ownership trends
.

How do I buy shares of Fortress Biotech?

Shares of FBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fortress Biotech's stock price today?

One share of FBIO stock can currently be purchased for approximately $0.83.

How much money does Fortress Biotech make?

Fortress Biotech (NASDAQ:FBIO) has a market capitalization of $89.31 million and generates $68.79 million in revenue each year. The biopharmaceutical company earns $-64,700,000.00 in net income (profit) each year or ($1.05) on an earnings per share basis.

How many employees does Fortress Biotech have?

The company employs 173 workers across the globe.

How can I contact Fortress Biotech?

Fortress Biotech's mailing address is 2 GANSEVOORT STREET 9TH FLOOR, NEW YORK NY, 10014. The official website for the company is www.fortressbiotech.com. The biopharmaceutical company can be reached via phone at (781) 652-4500, via email at ir@fortressbiotech.com, or via fax at 781-652-4545.

This page (NASDAQ:FBIO) was last updated on 2/7/2023 by MarketBeat.com Staff